ADARx Pharmaceuticals Prices Upsized $446M IPO at $17 per Share
ADARx Pharmaceuticals priced its upsized initial public offering of 26.25 million shares at $17.00 per share on September 24, 2026, hitting the high end of its $15 to $17 range. … Read More